I highly doubt that ALA will ever reach $1 or achieve a MC of $840 million. The company is being positioned for a sale and will likely be acquired well before reaching $1, especially if its results align with the preferences of a larger pharma.
For what it's worth, Mink Therapeutics (INKT) hit a low of $1 in early May but has since rebounded to $3.30 (+22% last night), with a MC of A$165 million.
Ann: Becoming a substantial holder RM, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.5¢ | 13.5¢ | $174.0K | 1.245M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61995 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 183155 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |